Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

Background We systematically assessed benefits and harms of the use of ivermectin (IVM)
in patients with coronavirus disease 2019 (COVID-19). Methods Published and preprint …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed
our lives. The scientific community has been investigating re-purposed treatments to prevent …

Updates This is the second version (first update) of the living systematic review, replacing
the previous version (available as a data supplement). When citing this paper please …

Objective Ivermectin has been suggested as a treatment for COVID-19. This randomised
control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and …

Melatonin, an endogenously synthesized indolamine, is a powerful antioxidant exerting
beneficial action in many pathological conditions. Melatonin protects from oxidative stress in …

Background: We provided a comprehensive evaluation of efficacy of available treatments for
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …

Objectives In this randomized open-label trial pilot study we assessed the antiviral effects
and safety of various doses of ivermectin in patients with mild clinical symptoms of COVID …

Background. Ivermectin has received particular attention as a potential treatment for COVID-
19. However, the evidence to support its clinical efficacy is controversial. Objectives. We …

Objectives Ivermectin, an antiparasitic agent, also has antiviral properties. In this study, we
aimed to assess whether ivermectin has anti-SARS-CoV-2 activity. Methods In this double …